Page 78 - Mercy MOR All Regions_FinalwVideo

Kentucky Variance % Variance Prior
Key Performance Indicators Net Patient Revenue 1,135 20.0% ($1,254,391) -30.3% $22,177,541
Actual
Budget
Metric
$4,906,009
$4,941,692
$5,886,666
Supply Expense
-19.1%
($944,974)
-5.1%
$24,721,727
$23,467,336
Supply Expense % Net Patient Revenue
5.1%
25.5%
25.1%
22.1%
($608)
$2,003
$2,612
Supply Expense per EIPA
$2,004
1,110
25
2.3%
1,119
Total Admissions
4,896
4,781
Total Patient Days

5,165
269
5.5%
2,450
-8.6%
2,254
(212)
2,466

Total EIPAs
IP Surgeries

598
4.4%
573
25
OP Surgeries
522
764
-6.5%
825
(54)
771

Total Surgeries
Outpatient Cath Lab Procedures 173 253 (80) -31.6% 242
0.0%
103
103
99

-
Site Performance Summary
KY Supply is unfavorable to budget by $917K with increases in Admission by 2%, outpt surgeries 4.4%, cath lab 3%, and Total Gross
Revenue 2.1%. Experienced decreases in ED by 4%, Observations 1%, Inpt surgeries 31%, and MRI 12%. The primary driver of the
variance is due to the pharmacy drug supply spend running over budget by $539K. This is essentially due to one patient that has used
$433k of Feiba, antihemophilic agent, during his stay. The pharmacy also received $217K in missed invoices from FFF that should
have went into 2017. The secondary driver is Implant other, unfavorable by $404K. This is mainly due to an increase in Impella &
AAA procedures; 8 impellas totaling $200k vs 2 in Jan 2017 and 6 AAA cases totaling $66K vs 2 in 2017. Cardiology implant utilization
is up 50% (187K) in CRM devices and 35% (29K) in our stent utilization over January 2017. Flu related expense has increase supply
spend in KY region by $37K. Non-Medical supply is unfavorable due to $16K in IT equipment vs $700 in 2017. Acheived savings in 3rd
party $11K, 340B program $80K, Bulk buys $7K, and Aquamantys utilization savings at $4K.
Key Challenges
Kentucky Leader's Summary
OR- Aquamnatys utilization is at 42 with 42 hips. Savings of $4,320 on knees.
Increased spend of $5k over last January on isolation supplies; isolation gowns, masks,
Med/Surg
stethoscopes and disposable bp cuff.
Cath lab- 4 Cryocaths were placed totaling $18K vs 1 in 2017
One patient on Feiba an antihemophilic agent spend is $433k for the month. Reimbursement
will be $472K.
Rx
FFF Invoices from 2017 totaling $217K.
340B savings of $80K
Cardiology Implants: 50% incremental usage in Pacemaker/leads (187K). Stent utilization is up
35% ($29K).
Spine & Ortho Implants: Increased Spine cases to 63 vs 54 last year. 2 Stimulator totaling $47K
Implants vs none last year. Increased Ortho cases 116 vs 113. Decreased Stem extenders by 12 ($10k).
Implant Other: 8 impellas placed ($200K) vs 2 ($50K) last January. 4 AAA cases total $47K vs 2
last year. 2 shunts placed at $10K vs none last year.
Minor Equip: $8K for two treadmills. Will be reimbursed by Foundation. $2,600 for Centrifuge
equip at M&W. Sleep Center Home sleep test was not repairable- $3,900
Other Expenses
Lab: $21K in flu test kits ($15,080 Lourdes/$6,530 at Marcum) vs $6,906 in Jan 2017.
Non-medical Equipment: $15,946 in IT equipment vs $700 last year
Actions Taken/Planned:
Plan to be in line with all Med/surg product changes before the end of the month.
3rd party savings at 10,822. Bulk buy savings $6,390.
Ortho Surgeons have stopped using Aquamnatys on the knees (90 days now) and they are
being more careful of whom they use Extended Stems on. Watching BMI and the reps have
been made aware this product is not to be one opened in a case unless the surgeon specifies.
Dr. Patel has been the biggest change.